Highly Efficient Chemoenzymatic Synthesis of α-Galactosyl Epitopes with a Recombinant α(1→3)-Galactosyltransferase

α-Galactosyl epitopes are carbohydrate structures bearing a Galα1-3Galβ terminus. The interaction of these epitopes on the surface of animal cells with anti-α-galactosyl antibodies in human serum is believed to be the main cause in antibody-mediated hyperacute rejection in xenotransplantation. This...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 120; no. 27; pp. 6635 - 6638
Main Authors Fang, Jianwen, Li, Jun, Chen, Xi, Zhang, Yingnan, Wang, Jianqiang, Guo, Zhengmao, Zhang, Wei, Yu, Libing, Brew, Keith, Wang, Peng George
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 15.07.1998
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:α-Galactosyl epitopes are carbohydrate structures bearing a Galα1-3Galβ terminus. The interaction of these epitopes on the surface of animal cells with anti-α-galactosyl antibodies in human serum is believed to be the main cause in antibody-mediated hyperacute rejection in xenotransplantation. This report describes an efficient chemoenzymatic approach based on the use of recombinant α(1→3)-galactosyltransferase (α1,3-GalT) for the synthesis of xenoactive α-galactosyl epitopes, which are highly desired in the research of xenotransplantation and immunotherapy. A truncated bovine α1,3-GalT (80−368) was cloned into the pET15b vector and subsequently transformed into E. coli BL21 strain. This expression system efficiently produced the soluble recombinant enzyme on a large scale with highly specific activity. A variety of α(1→3)-galactosylated epitopes were synthesized using such a recombinant enzyme. In a unique fashion, α-galactosyl pentasaccharide was synthesized via a one-pot, two-step enzymatic synthesis with in situ cofactor regeneration.
Bibliography:istex:F5D4C4B46A5ADEADEF78BDD8C5836AD4307B63B4
ark:/67375/TPS-TN2HXGWZ-K
ISSN:0002-7863
1520-5126
DOI:10.1021/ja9808898